Floatz logo

Cald Hr-D

Zellweger Syndrome

Masonic Cancer Center, University of MinnesotaunclassifiedPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Zellweger Syndrome cohort.

Asset / SponsorPhaseRating
Hydroxychloroquine
The Hospital for Sick Children
Phase 2B
CHOLALIC ACID
Mirum Pharmaceuticals, Inc.
Phase 3B
URSODEOXYCHOLIC ACID
N/AD
Chenodeoxycholic Acid
N/AD

Same molecule, other indications

Cald Hr-D is also rated in:

mucopolysaccharidosisDormant
CCC
Indicative ·
53 / 100
View asset →
Hurler syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
peroxisome biogenesis disorderDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →